Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Apr 15, 2017; 9(4): 142-152
Published online Apr 15, 2017. doi: 10.4251/wjgo.v9.i4.142
Published online Apr 15, 2017. doi: 10.4251/wjgo.v9.i4.142
Table 1 DNA integrity index in colorectal cancer patients
Table 2 Abnormally methylated genes as potential circDNA blood-based colorectal cancer detection biomarkers
| Potential biomarkers | CRC sensitivity (%) | CRC specificity (%) | Ref. |
| ALX4 | 40-83 | 70-82 | [67,76] |
| TFPI2 | 76-89 | - | [77-80] |
| SDC2 | 92 | - | [81] |
| RUNX3 | 65 | 100 | [82,83] |
| NEUROG1 | 52-64 | 91 | [84] |
| MGMT | 39 | 96 | [74] |
| RARβ2 | 24 | 100 | [74] |
| NGFR | 51 | 84 | [85] |
| 9-Sep | 48-90 | 86-93 | [64-67,70,86] |
| TMEFF2 | 65 | 69 | [85] |
| Vimentin | 59 | 93 | [41] |
| RASSF2A | 58 | 100 | [74] |
| Wif-1 | 74 | 98 | [74] |
| APC | 6 | 100 | [87] |
| hMLH1 | 43 | 98 | [87] |
| HTLF | 21-34 | 98-100 | [87,88] |
| SFRP2 | 67 | 94 | [89] |
| CDKN2A/P16 | 71 | 100 | [83] |
| Panel: SEPT9, HLTF and ALX4 | 74-88 | 90-96 | [68] |
| Panel: SEPT9 and ALX4 | - | - | [67] |
| Panel: MGMT, RASSF2A, Wif-1 gene | 86.5 | - | [74] |
| Panel: BMP3, NDRG4, vimentin, TFPI2, mutant KRAS and β-actin | 87 | - | [69] |
| Panel: AGTR1, WNT2, SLIT2 | 78 | - | [71] |
| Panel: CINP1, FBN1, INA, SNCA, MAL and SPG20 | 90-99 | - | [73] |
| Panel: CYCD2, HIC1, PAX5, RASSF1A, RB1 and SRBC | 84 | 68 | [72] |
| Panel: THBD and C9orf50 | 71 | 80 | [75] |
| RASSF1A, E-cadherin | - | - | [72,90] |
| CAHM | - | - | [91] |
| FRP2, TPEF/HPP1 | - | - | [83,84,92] |
- Citation: Galanopoulos M, Tsoukalas N, Papanikolaou IS, Tolia M, Gazouli M, Mantzaris GJ. Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature. World J Gastrointest Oncol 2017; 9(4): 142-152
- URL: https://www.wjgnet.com/1948-5204/full/v9/i4/142.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i4.142
